← Back to Bills
HR 7669118th CongressFailed / ExpiredHouse

Right to Try IVF Act of 2024

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 16, 2024
Latest Action Date
Mar 15, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Right to Try IVF Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing issues related to in vitro fertilization (IVF). The bill was referred to the Subcommittee on Health but did not advance further and ultimately failed or expired. There is no official summary or full text available, limiting detailed analysis of its provisions. The bill falls within the health policy area and appears to focus on expanding or protecting rights related to IVF treatments.

Bottom Line

The Right to Try IVF Act of 2024 sought to legislate aspects of IVF treatment rights but did not progress beyond early committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is titled the Right to Try IVF Act of 2024 and was introduced in the House of Representatives during the 118th Congress.
  • It was referred to the Subcommittee on Health on March 15, 2024, but no further legislative action was recorded.
  • No official summary or full text is publicly available, limiting detailed understanding of the bill's specific provisions or mechanisms.
Who Benefits?

['Individuals seeking access to or rights related to in vitro fertilization treatments', 'Healthcare providers and clinics specializing in reproductive health and IVF', 'Potentially relevant health agencies overseeing reproductive health policies']

Potential Concerns

['Lack of publicly available full text and summary limits transparency and understanding of implementation requirements', 'Unclear funding mechanisms or enforcement provisions may pose challenges if enacted', 'Absence of detailed oversight or authority structures in the available data restricts assessment of accountability measures']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance beyond this stage and is listed as failed or expired. The legislative context suggests limited momentum or prioritization within the current Congress. The health policy area indicates alignment with ongoing discussions about reproductive rights and medical treatment access.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential increased demand for IVF services if the bill intended to expand access or rights, impacting healthcare providers and insurance systems', "Possible shifts in regulatory oversight or standards for IVF treatments depending on the bill's provisions", "Influence on future legislative efforts related to reproductive health and patient rights due to the bill's introduction and referral"]

GovScope Watchdog Notes

The absence of an official summary and full bill text significantly limits transparency and public oversight. Without detailed provisions, it is difficult to assess the bill's scope, funding, enforcement, or potential impacts fully. Monitoring future bills on similar topics will be important to ensure comprehensive analysis and accountability.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready